Xconomy National

Archives

by in

Entry	Author	Date	Location
Cheezburger CEO Ben Huh’s Amazing Story of Survival	Curt Woodward	12/01/11	Seattle
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases	Arlene Weintraub	10/18/11	Boston
PureTech Ventures Launches Tal Medical To Develop Magnetic-Field Treatment for Depression	Arlene Weintraub	06/13/11	Boston
Prexa Pulls In $7M From Advent, Shire	Erin Kutz	05/11/11	Boston
Why Are Drugs Getting Such Weird Brand Names?	Luke Timmerman	05/09/11	National
Clinical Data’s Billionaire Chairman a Major Player in Firm’s Newly FDA-Approved Antidepressant	Ryan McBride	01/25/11	Boston
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients	Luke Timmerman	11/09/10	San Diego
BrainCells Inc. Buys Neuro Drug	Luke Timmerman	08/04/10	San Diego
Oclaro Buys Mintera, Gazelle Gets $12M, Genzyme Buyout Rumors Swirl, & More Boston-Area Deals News	Erin Kutz	07/28/10	Boston
Taris Hires New CEO, Stromedix Hopes Clinical Trial Will Advance, Euthymics Hits the Ground With Series A, & More Boston-Area Life Sciences News	Erin Kutz	07/23/10	Boston
Euthymics, Led by Orexigen Vet, Nabs $24M for Depression Drug With Fewer Side Effects	Luke Timmerman	07/22/10	Boston
Brain Cells’ Antidepressant Disappoints in Clinical Study, Otonomy Hears the Sound of Money, Cognionics Wins Startup Competition, & More San Diego Life Sciences News	Denise Gellene	06/17/10	San Diego
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News	Erin Kutz	06/16/10	Boston
Clinical Data Closes $32M Offering	Ryan McBride	06/14/10	Boston
BrainCells Inc, With Novel Depression Drug, Seeks a Way Forward After Mixed Result	Luke Timmerman	06/14/10	San Diego
eCBT Trauma Tracks PTSD Symptoms	Erin Kutz	03/30/10	National
PatientsLikeMe Growing as Pharma Customers Boost Focus on Patients	Ryan McBride	02/10/10	Boston
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood	Luke Timmerman	02/04/10	Boston
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug	Luke Timmerman	02/02/10	San Diego
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood	Luke Timmerman	01/19/10	Boston
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting	Gregory T. Huang	11/06/09	Seattle
Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete	Luke Timmerman	09/02/09	San Diego
BrainCells Inc., Defying Convention, Suggests Novel Drug Combination Can Treat Depression	Luke Timmerman	08/03/09	San Diego
BrainCells Depression Drug Reaches Goal	Luke Timmerman	07/27/09	San Diego
Psylin Neurosciences—-Amylin’s Pysch-Drug Offspring—Nearing First Clinical Trial	Ryan McBride	04/27/09	San Diego
FDA Rejects Somaxon’s Application for Insomnia Drug	Bruce V. Bigelow	02/26/09	San Diego
Arena Weight Loss Drug Approaches Critical Turning Point Next Month	Luke Timmerman	02/11/09	San Diego
TheraGenetics Bought by Avacta	Luke Timmerman	01/29/09	Boston
Cypress Bioscience Shares Soar on News of FDA Approval	Bruce V. Bigelow	01/15/09	San Diego
Northstar Neuroscience Shuts Down, Ending Experimental Depression Trial	Luke Timmerman	01/05/09	Seattle
Page 1 of 2	next page »